Navigating the Early Asset Evaluation Journey with Confidence

Available On Demand

There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.

Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common pitfalls they must avoid to navigate the early asset evaluation journey with confidence.

Key Webinar Topics

• What are the critical questions along the asset evaluation journey?
• How do you identify which indication to prioritize to maximize value?
• How do you bring various internal stakeholders to the table?
• How can you drive smart, lean insights and analytics for a new asset?
• When and how do you typically consider regionality in the process?

Featuring

Complete the form below to view the on-demand webinar.

We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.